IL89287A - Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy - Google Patents

Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy

Info

Publication number
IL89287A
IL89287A IL89287A IL8928789A IL89287A IL 89287 A IL89287 A IL 89287A IL 89287 A IL89287 A IL 89287A IL 8928789 A IL8928789 A IL 8928789A IL 89287 A IL89287 A IL 89287A
Authority
IL
Israel
Prior art keywords
compositions containing
acid derivatives
phosphonic acid
tumor therapy
aspartate transcarbamylase
Prior art date
Application number
IL89287A
Other languages
English (en)
Other versions
IL89287A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL89287A0 publication Critical patent/IL89287A0/xx
Publication of IL89287A publication Critical patent/IL89287A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL89287A 1988-02-16 1989-02-14 Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy IL89287A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400348A EP0328834A1 (en) 1988-02-16 1988-02-16 Novel aspartate transcarbamylase inhibitors

Publications (2)

Publication Number Publication Date
IL89287A0 IL89287A0 (en) 1989-09-10
IL89287A true IL89287A (en) 1993-02-21

Family

ID=8200350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89287A IL89287A (en) 1988-02-16 1989-02-14 Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy

Country Status (12)

Country Link
EP (2) EP0328834A1 (xx)
JP (1) JPH02149589A (xx)
CN (1) CN1036207A (xx)
AU (1) AU609942B2 (xx)
DK (1) DK69489A (xx)
FI (1) FI890695A (xx)
HU (1) HUT49142A (xx)
IL (1) IL89287A (xx)
NO (1) NO890644L (xx)
NZ (1) NZ227978A (xx)
PT (1) PT89718B (xx)
ZA (1) ZA891078B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2085446T3 (es) * 1990-07-04 1996-06-01 Merrell Pharma Inc Derivados de acido 9-purinil fosfonico.
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
GB9200826D0 (en) * 1992-01-15 1992-03-11 Celltech Ltd Peptidyl derivatives
JP7037069B2 (ja) * 2016-09-14 2022-03-16 ダイキン工業株式会社 分枝含フッ素化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
FR2590259B1 (fr) * 1985-11-20 1989-05-12 Roussel Uclaf Procede de preparation de derives fluores de l'acide phosphonique, et produits obtenus par la mise en oeuvre de ce procede
FR2596393B1 (fr) * 1986-04-01 1988-06-03 Sanofi Sa Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant

Also Published As

Publication number Publication date
FI890695A (fi) 1989-08-17
CN1036207A (zh) 1989-10-11
HUT49142A (en) 1989-08-28
EP0331550A1 (en) 1989-09-06
NO890644L (no) 1989-08-17
NO890644D0 (no) 1989-02-15
AU609942B2 (en) 1991-05-09
FI890695A0 (fi) 1989-02-14
JPH02149589A (ja) 1990-06-08
NZ227978A (en) 1990-10-26
AU2990489A (en) 1989-08-17
ZA891078B (en) 1989-10-25
EP0328834A1 (en) 1989-08-23
PT89718B (pt) 1994-03-31
PT89718A (pt) 1989-10-04
DK69489D0 (da) 1989-02-15
IL89287A0 (en) 1989-09-10
DK69489A (da) 1989-08-17

Similar Documents

Publication Publication Date Title
IL86464A (en) 4-phosphinyl-3- hydroxybutanoic acid derivatives useful as cholesterol biosynthesis inhibitors and pharmaceutical compositions containing the same
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
NZ216307A (en) Pharmaceutical compositions containing tissue plasminogen activator
PT82294B (en) Process for the preparation of arylethanolamine derivatives and of pharmaceutical compositions containing the same
NZ215333A (en) Cephem compounds and pharmaceutical compositions
IL81001A0 (en) Compositions for bone healing containing omental lipids
IL85969A0 (en) Ribofuranuronic acid derivatives and pharmaceutical compositions containing them
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
GB2205745B (en) Use of dioxopiperidine derivatives as analgesics
IL89287A (en) Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy
EP0342139A3 (en) Medicine containing arginine aspartate for treating inflictions of the memory
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
ZA8614B (en) Basic formulations of quinolonecarboxylic acids
EP0419998A3 (en) Use of alkylphosphonic acid derivatives for the treatment of psoriasis
IL87182A0 (en) Pharmaceutical compositions containing tumor necrosis factor for treating infections
HU8905409D0 (en) Process for the preparation of compositions containing ace inhibitor suitable for the treatment of postischaemic cardiac disturbances
IL93590A0 (en) Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
AU3510489A (en) Pharmaceutical composition for treating tumor
HUT42463A (en) Herbicide compositions containing thiazolyl-amide derivatives as active agents and process for producing thiazolyl-amide derivatives
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
PT82656A (en) Process for the preparation of aducts of aluminium-amine phosphinate and of fungicidal compositions containing the same
AU5816786A (en) Metal salts of mixed aromatic/aliphatic phosphorodithioic acids
IE890485L (en) Aspartate transcarbamylase inhibitors

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.